Inogen (INGN) EBT (2013 - 2026)

Inogen (INGN) has reported EBT for 14 consecutive years, with -$4.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT rose 6.99% year-over-year to -$4.0 million in Q2 2026; TTM through Jun 2026 was -$25.3 million, a 5.32% increase from a year earlier, with the FY2025 full-year figure at -$23.4 million, up 35.91% from the prior year.
• EBT was -$4.0 million for Q2 2026 at Inogen, up from -$8.5 million in the prior quarter.
• Over five years, EBT peaked at -$3.4 million in Q2 2022 and troughed at -$57.6 million in Q4 2022.
• A 5-year average of -$14.4 million and a median of -$9.0 million in 2022 frame the typical range for EBT.
• Across the five-year window, EBT tumbled 736.45% in 2022 and soared 86.62% in 2024, its largest moves.
• Over 5 years, EBT stood at -$57.6 million in 2022, then surged by 52.99% to -$27.1 million in 2023, then soared by 62.76% to -$10.1 million in 2024, then increased by 27.01% to -$7.4 million in 2025, then jumped by 45.62% to -$4.0 million in 2026.
• The last three EBT figures came in at -$4.0 million (Q2 2026), -$8.5 million (Q1 2026), and -$7.4 million (Q4 2025), per Business Quant data.